Prof. Mohammad ALOLAMAUnited Arab Emirates
Dubai Health
2012 to present | Consultant neurosurgeon |
2021 - 2024 | Director of residency program for neurosurgery |
2012 - | Functiona, vascular an dpediatric neurosurgeon. |
Functional and pediatric as well as vascular.
Dr. Mohammad Abdulaziz Sultan Al Olama is a consultant neurosurgeon at Rashid Hospital and also works at the University Hospital in Sharjah as a visiting doctor. He is specialized in pediatric neursurgery, advanced neuropathic pain, and functional neurosurgery. He studied medicine in Sweden at the University of Gothenburg, trained at Frankston Hospital affiliated with Monash University in Melbourne, Australia, worked in the General Surgery Department at Al Baraha Hospital for a year, then studied neurosurgery at Sahlgrenska University Hospital in Gothenburg, Sweden. He has trained in various fields, such as the Gamma Knife device at Karolinska Hospital in Sweden, Pittsburgh Hospital in USA, and Johnston Willis Hospital in Richmond, Verginia in USA. He also trained in fetal operations at Arnold Palmer Hospital in Orlando, USA. He was also trained on MRI-Focused ultrasound in Milan, Italy, and the ZapX device in Zurich. He is also an assistant professor at Mohammed bin Rashid Medical University and also holds a master’s degree in executive public administration from the Mohammed bin Rashid College of Governance and he is among the nine most prominent graduates ever.
He is the director of the neurosurgery residency program at the Dubai Health, which is the only program in the country.
Dr. Mohammad Al Olama was the first to use the endoscope for brain surgeries in the Dubai Health. He was the one who introduced reprogrammable shunt devices to treat hydrocephalus in the Emirates. He also introduced many advanced tools for brain operations to the country.
He was honored by Sheikh Mohammed bin Rashid as one of the pioneers in the Emirates, as he was the first to measure brain pressure in rats for weeks, as he invented a method for this, and it was the first time in the world that brain pressure was measured in rats that were awake and active. He was also honored by the Dubai Health Authority. As the first Emirati pediatric brain surgeon, and also as a distinguished doctor, he was also honored by the Ministry of Health as a distinguished doctor, and the Emarat Al Youm newspaper also honored him as a Personality of November 2015. He was the first to perform an operation on a fetus due to myelomeningocele, which is the first operation of its kind in the Arab world.
He is the one who founded the Emirates Society of neurological surgeons and is the organizer of the annual Emirates International Neurosurgery Congress. He is the General Secretary of the Arab Pediatric neurosurgical society, President of the Gulf Neurosurgical Society, and Secretary of the Asian-Australian Neurosurgical Society. He is a former member of the Emirates Council of scientists and former Vice President of the Emirates Medical Association. He has presented many lectures and workshops at regional and international conferences. He is a former member of the World Economic Forum's Neurotechnology Committee.
Dr. Mohammad Al-Olama has many research papers published in the most prestigious scientific journals, including publishing the world’s first case of brain hemorrhage and meningitis due to the Corona virus. He is an active member of neurosurgical journals in reviewing scientific papers.
Dr Mohammad brought many societies meeting to Dubai: Dandy society in 2015, Leksell Gamma Knife society meeting in 2018, IFNE interim meeting in 2024. Helped with other societies to bring big meetings to Dubai like ACNS in 2018, WSSFN in 2023 and IESS in 2024. He recently won the WFNS bid for Dubai in 2025.
Finally, Dr. Mohammed Al Olama was chosen as Personality No. (4) among the 100 most powerful people in Dubai who should be known, according to Arabian Business magazine, issued in February 2023.
The role of MRI-focused ultrasound in neurosurgery and our experience
1110 10:20-10:30
Functional Neurosurgery & Epilepsy/304A
Magnetic resonance-guided focused ultrasound (MRgFUS) is a novel technique that uses high-intensity focused ultrasound to achieve target ablation in same targets as deep brain stimulation. these ultrasound waves are focused to generate heat. This therapy combines the noninvasiveness of Gamma Knife thalamotomy and the real-time ablation of deep brain stimulation with acceptable complication rates. The system is approved to treat tremors in cases of essential tremor and Parkinson's tremor. It is also treating rigidity, bradykinesia and dyskinesia. We show our experience with the machine and how helpful it is for patients.